WallStreetZenWallStreetZen

NASDAQ: MPLT
Maplight Therapeutics Inc Stock Ownership - Who owns Maplight Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Maplight Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jonathan GillisCAAO and PAO2026-04-28700$30.83
$21.58kSell
Jonathan GillisCAAO and PAO2026-04-2817,235$30.33
$522.74kSell
Anatol KreitzerChief Discovery Officer2026-04-277,821$30.50
$238.54kSell
Anatol KreitzerChief Discovery Officer2026-04-278,346$28.96
$241.70kSell
Jonathan GillisCAAO and PAO2026-04-277,914$28.94
$229.03kSell
Jonathan GillisCAAO and PAO2026-04-2714,363$30.46
$437.50kSell
Jonathan GillisCAAO and PAO2026-04-2729,623$29.60
$876.84kSell
Anatol KreitzerChief Discovery Officer2026-04-2729,255$29.63
$866.83kSell
Kristopher HansonGeneral Counsel2026-04-16225$27.49
$6.19kSell
Vishwas SetiaChief Financial Officer2026-04-1629$27.01
$783.29Sell

1 of 6

MPLT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MPLT insiders and whales buy or sell their stock.

MPLT Shareholders

What type of owners hold Maplight Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Catalyst4 Inc46.42%19,697,464$627.76MInsider
Holdings A. Novo8.69%3,686,622$117.49MInsider
Novo Holdings A8.69%3,686,622$117.49MInstitution
Fcpm III Services Bv7.60%3,226,400$102.83MInstitution
T Rowe Price Investment Management Inc6.60%2,799,180$89.21MInstitution
Goldman Sachs Group Inc 14.56%1,937,168$61.74MInstitution
Goldman Sachs Group Inc4.56%1,937,168$61.74MInstitution
Christopher A. Kroeger4.08%1,731,754$55.19MInsider
Blackrock Inc2.58%1,095,514$34.91MInstitution
Nan Fung Group Holdings Ltd2.29%971,253$30.95MInstitution

1 of 3

MPLT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MPLT45.86%54.14%Net BuyingNet Selling
CRVS55.58%38.94%Net Buying
NVAX72.31%17.28%Net SellingNet Selling
GHRS75.07%24.19%
AVBP80.12%19.88%Net Selling
View Top Biotech Stocks

Maplight Therapeutics Stock Ownership FAQ

Who owns Maplight Therapeutics?

Maplight Therapeutics (NASDAQ: MPLT) is owned by 54.35% institutional shareholders, 64.17% Maplight Therapeutics insiders, and 0.00% retail investors. Catalyst4 Inc is the largest individual Maplight Therapeutics shareholder, owning 19.70M shares representing 46.42% of the company. Catalyst4 Inc's Maplight Therapeutics shares are currently valued at $604.71M.

If you're new to stock investing, here's how to buy Maplight Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.